본문 바로가기
KERD
논문KCI 등재

Anti-osteoporotic effect of Boswellia serrata gum resin extract in vitro and in vivo

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

AbstractBACKGROUND/OBJECTIVESThis study evaluated the beneficial effects of an ethanol extract of Boswellia serrata gum resin (FJH-UBS) in osteoporosis. MATERIALS/METHODSMC3T3-E1 osteoblastic cells and RAW 264.7 osteoclastic cells were treated with FJH-UBS. The alkaline phosphatase (ALP) activity, mineralization, collagen synthesis, osteocalcin content, and Runt-related transcription factor 2 (RUNX2) and Osterix expression were measured in MC3T3-E1 cells. The actin ring structures, tartrate-resistant acid phosphatase (TRAP) activity, and the nuclear factor of activator T-cells, cytoplasm 1 (NFATc1) expression were evaluated in RAW 264.7 cells. Ovariectomized ICR mice were orally administered FJH-UBS for eight weeks. The bone mineral density (BMD) and the serum levels of osteocalcin, procollagen 1 N-terminal propeptide (P1NP), osteoprotegerin, and TRAP 5b were analyzed. RESULTSFJH-UBS increased the ALP activity, collagen, osteocalcin, mineralization, and RUNX2 and osterix expression in MC3T3-E1 osteoblastic cells, whereas it decreased the TRAP activity, actin ring structures, and NFATc1 expression in RAW 264.7 osteoclastic cells. In ovariectomy-induced osteoporosis mice, FJH-UBS positively restored all of the changes in the bone metabolism biomarkers (BMD, osteocalcin, P1NP, osteoprotegerin, and TRAP 5b) caused by the ovariectomy. CONCLUSIONFJH-UBS has anti-osteoporotic activity by promoting osteoblast activity and inhibiting osteoclast activity in vitro and in vivo, suggesting that FJH-UBS is a potential functional food ingredient for osteoporosis.

Abstract

AbstractBACKGROUND/OBJECTIVESThis study evaluated the beneficial effects of an ethanol extract of Boswellia serrata gum resin (FJH-UBS) in osteoporosis. MATERIALS/METHODSMC3T3-E1 osteoblastic cells and RAW 264.7 osteoclastic cells were treated with FJH-UBS. The alkaline phosphatase (ALP) activity, mineralization, collagen synthesis, osteocalcin content, and Runt-related transcription factor 2 (RUNX2) and Osterix expression were measured in MC3T3-E1 cells. The actin ring structures, tartrate-resistant acid phosphatase (TRAP) activity, and the nuclear factor of activator T-cells, cytoplasm 1 (NFATc1) expression were evaluated in RAW 264.7 cells. Ovariectomized ICR mice were orally administered FJH-UBS for eight weeks. The bone mineral density (BMD) and the serum levels of osteocalcin, procollagen 1 N-terminal propeptide (P1NP), osteoprotegerin, and TRAP 5b were analyzed. RESULTSFJH-UBS increased the ALP activity, collagen, osteocalcin, mineralization, and RUNX2 and osterix expression in MC3T3-E1 osteoblastic cells, whereas it decreased the TRAP activity, actin ring structures, and NFATc1 expression in RAW 264.7 osteoclastic cells. In ovariectomy-induced osteoporosis mice, FJH-UBS positively restored all of the changes in the bone metabolism biomarkers (BMD, osteocalcin, P1NP, osteoprotegerin, and TRAP 5b) caused by the ovariectomy. CONCLUSIONFJH-UBS has anti-osteoporotic activity by promoting osteoblast activity and inhibiting osteoclast activity in vitro and in vivo, suggesting that FJH-UBS is a potential functional food ingredient for osteoporosis.

참고문헌 (46)

  1. Hwang YH, "Suppression effect of astaxanthin on osteoclast formation in vitro and bone loss in vivo", Int J Mol Sci, 19, pp.912~ (2018)
  2. Langdahl BL, "Overview of treatment approaches to osteoporosis", Br J Pharmacol, 178, pp.1891~1906 (2021)
  3. Li SS, "Recent progresses in the treatment of osteoporosis", Front Pharmacol, 12, pp.717065~ (2021)
  4. He JB, "New insights into the tonifying kidney-yin herbs and formulas for the treatment of osteoporosis", Arch Osteoporos, 12, pp.14~ (2017)
  5. Russell RG, "Bisphosphonates : an update on mechanisms of action and how these relate to clinical efficacy", Ann N Y Acad Sci, 1117, pp.209~257 (2007)
  6. O’Ryan FS, "Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure : clinical course and outcomes", J Oral Maxillofac Surg, 70, pp.1844~1853 (2012)
  7. Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results From the Women’s Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
  8. Lee J, "Standardized ethanolic extracts of Boswellia serrata ameliorate symptoms of osteoarthritis by direct effects on chondrocytes", J Food Nutr Res, 9, pp.614~625 (2021)
  9. Majeed M, "A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee", Phytother Res, 33, pp.1457~1468 (2019)
  10. Mannino G, "Quantitative determination of 3-O-acetyl-11-keto-β boswellic Acid(AKBA)and other boswellic acids in Boswellia sacra Flueck(syn. B. carteri Birdw)and Boswellia serrata Roxb", Molecules, 21, pp.1329~ (2016)
  11. Roy NK, "An update on pharmacological potential of boswellic acids against chronic diseases", Int J Mol Sci, 20, pp.4101~ (2019)
  12. Zhang J, "GR-mediated anti-inflammation of α-boswellic acid : insights from in vitro and in silico studies", Food Chem Toxicol, 155, pp.112379~ (2021)
  13. Zimmermann-Klemd AM, "Boswellia carteri extract and 3-O-acetyl-alpha-boswellic acid suppress T cell function", Fitoterapia, 146, pp.104694~ (2020)
  14. Bharat KT, "Ingredients of a natural oral nutritional supplement and their role in the treatment of osteoarthritis", Clin Med Insights Arthritis Musculoskelet Disord, 15, pp.11795441211063365~ (2022)
  15. Mariano A, "The nutraceuticals as modern key to achieve erythrocyte oxidative stress fighting in osteoarthritis", Curr Issues Mol Biol, 44, pp.3481~3495 (2022)
  16. Al-Dhubiab BE, "The beneficial effect of boswellic acid on bone metabolism and possible mechanisms of action in experimental osteoporosis", Nutrients, 12, pp.3186~ (2020)
  17. Takada Y, "Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression", J Immunol, 176, pp.3127~3140 (2006)
  18. Xiong L, "Acetyl-11-keto-β-boswellic acid attenuates titanium particle-induced osteogenic inhibition via activation of the GSK-3β", β-catenin signaling pathway, 2019, pp.9, 7140~7155
  19. Jung JI, "Anti-osteoarthritis effect of enriched Boswellia serrata gum resin extract in SW1353 chondrocytes", J Korean Soc Food Sci Nutr, 52, pp.460~472 (2023)
  20. Jung JI, "Anti-osteoarthritis effect of Boswellia serrata gum resin extract in monosodium iodoacetate-induced osteoarthritic Sprague-Dawley rats", J Nutr Health, 56, pp.231~246 (2023)
  21. Denizot F, "Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability", J Immunol Methods, 89, pp.271~277 (1986)
  22. Lim SM, "Cyanidine-3-O-galactoside enriched Aronia melanocarpa extract inhibits adipogenesis and lipogenesis via down-regulation of adipogenic transcription factors and their target genes in 3T3-L1 cells", Food Nutr Sci, 10, pp.128~147 (2019)
  23. Kim EJ, "Aqueous extract of Petasites japonicus leaves promotes osteoblast differentiation via up-regulation of Runx2 and Osterix in MC3T3-E1 cells", Nutr Res Pract, 15, pp.579~590 (2021)
  24. Souza VR, "Description of ovariectomy protocol in mice", Methods Mol Biol, 1916, pp.303~309 (2019)
  25. Soysa NS, "Osteoclast function and bone-resorbing activity : an overview", Biochem Biophys Res Commun, 476, pp.115~120 (2016)
  26. Feng X, "Disorders of bone remodeling", Annu Rev Pathol, 6, pp.121~145 (2011)
  27. Fontalis A, "Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications : a systematic review and meta-analysis", Expert Opin Drug Saf, 17, pp.413~428 (2018)
  28. Singh P, "A-90 day gavage safety assessment of Boswellia serrata in rats", Toxicol Int, 19, pp.273~278 (2012)
  29. Dodda S, "Safety assessment of a novel water-soluble extract of Boswellia serrata gum resin : acute toxicity, 90-day sub-chronic toxicity, Ames’ bacterial reverse mutation, and in vivo micronucleus assays", Toxicol Mech Methods, 32, pp.362~372 (2022)
  30. Sharma T, "Investigation of molecular properties that influence the permeability and oral bioavailability of major β-boswellic acids", Eur J Drug Metab Pharmacokinet, 45, pp.243~255 (2020)
  31. Kim WJ, "RUNX2-modifying enzymes : therapeutic targets for bone diseases", Exp Mol Med, 52, pp.1178~1184 (2020)
  32. Liu Q, "Recent advances of osterix transcription factor in osteoblast differentiation and bone formation", Front Cell Dev Biol, 8, pp.601224~ (2020)
  33. Barbuto R, "Regulation of the osterix(Osx, Sp7)promoter by osterix and its inhibition by parathyroid hormone", J Mol Endocrinol, 51, pp.99~108 (2013)
  34. Hayman AR, "Tartrate-resistant acid phosphatase(TRAP)and the osteoclast", immune cell dichotomy, 2008, pp.41, 218~223
  35. Zhao Q, "NFATc1 : functions in osteoclasts", Int J Biochem Cell Biol, 42, pp.576~579 (2010)
  36. Zheng H, "Salidroside improves bone histomorphology and prevents bone loss in ovariectomized diabetic rats by upregulating the OPG", RANKL ratio, 2018, pp.23, 2398~
  37. Levis S, "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms : a randomized, double-blind trial", Arch Intern Med, 171, pp.1363~1369 (2011)
  38. Qi S, "Combined effects of phytoestrogen genistein and silicon on ovariectomy-induced bone loss in rat", Biol Trace Elem Res, 177, pp.281~287 (2017)
  39. Kim SM, "Effect of isoflavone-enriched whole soy milk powder supplementation on bone metabolism in ovariectomized mice", Nutr Res Pract, 12, pp.275~282 (2018)
  40. Yousefzadeh N, "Ovariectomized rat model of osteoporosis : a practical guide", EXCLI J, 19, pp.89~107 (2020)
  41. Fu SW, "Systematic review and meta-analysis of the bone protective effect of phytoestrogens on osteoporosis in ovariectomized rats", Nutr Res, 34, pp.467~477 (2014)
  42. Bonjour JP, "Biochemical markers for assessment of calcium economy and bone metabolism : application in clinical trials from pharmaceutical agents to nutritional products", Nutr Res Rev, 27, pp.252~267 (2014)
  43. Kuo TR, "Bone biomarker for the clinical assessment of osteoporosis : recent developments and future perspectives", Biomark Res, 5, pp.18~ (2017)
  44. Gillett MJ, "The role of PINP in diagnosis and management of metabolic bone disease", Clin Biochem Rev, 42, pp.3~10 (2021)
  45. Chen FP, "Association between P1NP and bone strength in postmenopausal women treated with teriparatide", Taiwan J Obstet Gynecol, 61, pp.91~95 (2022)
  46. Chen CY, "Extracellular vesicles from human urine-derived stem cells prevent osteoporosis by transferring CTHRC1 and OPG", Bone Res, 7, pp.18~ (2019)

관련 논문AI추천

이 간행물의 다른 논문 (10건)